The genes encoding the HLA-DQ heterodimer molecules, DQB1 and DQA1, have been found to have the strongest association with IDDM risk, although there is cumulative evidence for the effect of other gene loci within the major histocompatibility complex gene region. After the HLA-DQ locus, the HLA-DR locus has been suggested most often as contributing to the disease susceptibility. In this study we analyzed at the population level the effect of DR4 subtypes and class I, HLA-B alleles, on IDDM risk when the influence of the DQ locus was stratified. In all three populations studied (Estonian, Latvian, and Russian), DQB1*0302 haplotypes most frequently carried DRB1*0401 or DRB1*0404. DRB1*0401 was the most prevalent subtype in IDDM patients, whereas DRB 1*0404 was decreased in frequency. DRB 1*0402 was also prevalent among Russian haplotypes, but was not associated with IDDM risk. When HLA-B alleles were analyzed, strong associations between the presence of specific B alleles and DRB1*04 subtypes were detected. The HLA-B39 allele was found significantly more often in DRB1*0404-DQBl*0302-positive patients than in healthy control subjects positive for this haplotype: 27 of 54 (50%) vs. 4 of 49 (8.2%) (P < 0.0001). The results demonstrate that DQ and DR genes cannot explain all of the HLA-linked susceptibility to IDDM, and that the existence of a susceptibility locus telom-eric to DR is probable.
Original Articles|
November 01 1997
The Effect of HLA-B Allele on the IDDM Risk Defined by DRB1*04 Subtypes and DQB1*0302
Sergei Nejentsev;
Sergei Nejentsev
Turku Immunology Centre and Department of Virology, University of Turku
Turku, Finland
Department of Medical Genetics, Pediatric Medical Academy
St. Petersburg, Russia
Search for other works by this author on:
Helena Reijonen;
Helena Reijonen
Turku Immunology Centre and Department of Virology, University of Turku
Turku, Finland
Search for other works by this author on:
Bela Adojaan;
Bela Adojaan
Department of Endocrinology, Tartu University Hospital
Tartu, Estonia
Search for other works by this author on:
Liliya Kovalchuk;
Liliya Kovalchuk
Laboratory of Immunogenetics and Immunology, Latvian Medical Academy
Riga, Latvia
Search for other works by this author on:
Arthur Sochnevs;
Arthur Sochnevs
Laboratory of Immunogenetics and Immunology, Latvian Medical Academy
Riga, Latvia
Search for other works by this author on:
Eugene I Schwartz;
Eugene I Schwartz
Department of Medical Genetics, Pediatric Medical Academy
St. Petersburg, Russia
Search for other works by this author on:
Hans K Åkerblom;
Hans K Åkerblom
Children's Hospital, University of Helsinki
Helsinki, Finland
Search for other works by this author on:
Jorma Ilonen
Jorma Ilonen
Turku Immunology Centre and Department of Virology, University of Turku
Turku, Finland
Search for other works by this author on:
Address correspondence and reprint requests to Jorma Ilonen, Department of Virology, University of Turku, Kiinamyllynkatu 13, FIN-20520 Turku, Finland. E-mail: jorma.ilonen@utu.fi.
Diabetes 1997;46(11):1888–1892
Article history
Received:
March 03 1997
Revision Received:
June 23 1997
Accepted:
June 23 1997
PubMed:
9356041
Citation
Sergei Nejentsev, Helena Reijonen, Bela Adojaan, Liliya Kovalchuk, Arthur Sochnevs, Eugene I Schwartz, Hans K Åkerblom, Jorma Ilonen; The Effect of HLA-B Allele on the IDDM Risk Defined by DRB1*04 Subtypes and DQB1*0302. Diabetes 1 November 1997; 46 (11): 1888–1892. https://doi.org/10.2337/diab.46.11.1888
Download citation file: